Helen Lachmann Selected Research

Helen Lachmann Research Topics

Disease

21	Amyloidosis 05/2024 - 10/2002
10	Cardiomyopathies (Cardiomyopathy) 03/2024 - 01/2020
8	Immunoglobulin Light-chain Amyloidosis 03/2024 - 07/2015
6	Heart Failure 05/2024 - 12/2022
3	autosomal dominant familial Periodic fever 09/2023 - 09/2005
3	Necrosis 01/2020 - 05/2013
3	Cryopyrin-Associated Periodic Syndromes 06/2017 - 01/2011
2	Disease Progression 05/2024 - 03/2024
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2020 - 08/2018
2	Mevalonate Kinase Deficiency 01/2018 - 05/2013
2	Proteinuria 05/2014 - 10/2002
2	Fever (Fevers) 05/2013 - 09/2005
1	Polyneuropathies (Polyneuropathy) 03/2024
1	Hypoalbuminemia 02/2024
1	Hyperbilirubinemia 02/2024
1	Anemia 02/2024
1	Hyponatremia 02/2024
1	Hypoxia (Hypoxemia) 01/2024
1	Albuminuria 11/2023
1	Chronic Renal Insufficiency 11/2023
1	Body Weight (Weight, Body) 09/2023
1	Multiple Myeloma 09/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2023
1	Transthyretin-Related Hereditary Amyloidosis 01/2023
1	Hypertrophy 01/2023
1	VEXAS syndrome 12/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2020
1	COVID-19 01/2020
1	Schnitzler Syndrome 01/2020
1	Infections 01/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Rare Diseases (Rare Disease) 08/2018
1	Hodgkin Disease (Hodgkin's Disease) 01/2018
1	Exanthema (Rash) 06/2017
1	Aseptic Meningitis 06/2017
1	Urticaria (Hives) 06/2017
1	Sensorineural Hearing Loss 06/2017
1	Inflammation (Inflammations) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2014
1	Arthritis (Polyarthritis) 05/2013
1	Pharyngitis (Sore Throat) 05/2013

Drug/Important Bio-Agent (IBA)

15	Prealbumin (Transthyretin)IBA 05/2024 - 01/2020
11	Amyloid (Amyloid Fibrils)IBA 03/2024 - 10/2002
5	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 12/2022
5	Interleukin-1 (Interleukin 1)IBA 01/2020 - 01/2011
4	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2023
4	Troponin T (Troponin T1)IBA 02/2024 - 12/2022
4	AA amyloidosisIBA 01/2018 - 10/2002
3	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 01/2023
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2020 - 08/2018
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2011
2	DiureticsIBA 05/2024 - 03/2024
2	C-Reactive ProteinIBA 02/2024 - 06/2017
2	TroponinIBA 02/2024 - 01/2023
2	canakinumab FDA Link 09/2023 - 01/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2023 - 07/2015
2	Bortezomib (Velcade)FDA Link 09/2023 - 07/2015
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2023 - 01/2023
2	Immunoglobulin M (IgM)IBA 01/2020 - 10/2016
1	Clostridium perfringens epsilon-toxinIBA 03/2024
1	Alkaline PhosphataseIBA 02/2024
1	Urea (Carbamide)FDA LinkGeneric 02/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024
1	AlbuminsIBA 11/2023
1	CreatinineIBA 11/2023
1	Proteasome InhibitorsIBA 09/2023
1	carfilzomibIBA 09/2023
1	Thalidomide (Thalomid)FDA Link 09/2023
1	Trinitrotoluene (TNT)IBA 01/2023
1	Angiotensin Receptor AntagonistsIBA 01/2023
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Natriuretic PeptidesIBA 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	Prostaglandins AIBA 11/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	pomalidomideIBA 11/2018
1	InterleukinsIBA 08/2018
1	EnzymesIBA 01/2018
1	tocilizumab (atlizumab)FDA Link 01/2018
1	Terpenes (Terpenoids)IBA 01/2018
1	CholesterolIBA 01/2018
1	mevalonate kinaseIBA 01/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2017
1	Mitogen-Activated Protein Kinase 14IBA 01/2017
1	ParaproteinsIBA 10/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2015
1	Serum AlbuminIBA 05/2014

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
2	Therapeutics 01/2023 - 04/2015
2	Biological Therapy 08/2018 - 01/2011
1	Aftercare (After-Treatment) 03/2024
1	Stem Cell Transplantation 12/2022
1	Contraindications 01/2022
1	Heart Transplantation (Grafting, Heart) 01/2022
1	Critical Care (Surgical Intensive Care) 01/2020
1	Subcutaneous Injections 08/2018